Wired Herald

Personalized Medicine Market to Rise at a Estimation of US$ 1.7 Trillion by 2026

Press release   •   Jun 27, 2019 05:55 EDT

The Global Personalized Medicine Market Size is expected to reach around US$ 1.7 trillion by 2026 and will grow at noteworthy CAGR around 9.1 % over the forecast period.

Acumen Research and Consulting has recently published a research report on the Personalized Medicine Market for the forecast period of 2019-2026, wherein, the global market has been analyzed and assessed in an extremely comprehensive manner. The research report on the Personalized Medicine Market offers an extensive analysis of how the postoperative pain therapeutics landscape would evolve through 2026.

The research study on the Personalized Medicine Market analyzes key drivers upholding product sales and prominent trends shaping the growth of the market. The research study not only focuses on the latent opportunities for the key stakeholders of the market, but also sheds light on the notable developments and future scope for innovation in the landscape.

Free Download Sample Report Pages for Better Understanding@ https://www.acumenresearchandconsulting.com/request-sample/1466

The report starts off with a quick executive summary, wherein, key takeaways have been highlighted for the readers to have a sneak peak at the key market segments. The research study by ARC on the market also talks about the macroeconomic and microeconomic factors having deep-rooted influences on global market growth. The research study on the Personalized Medicine Market also offers a regional analysis, wherein, demand across every region has been comprehensively analyzed.

The report also analyzes the Personalized Medicine Market on the basis of various segments, with drug type being a prominent one. A unique section in the report also offers a detailed breakdown on the basis of route of administration – which one is highly preferred and which one is minimally preferred.

Market Segmentation

Market, By Product

  • Therapeutics
  • Diagnostics
  • Personalized Nutrition & Wellness
  • Personalized Medical Care

Market, By Geography

  • North America.
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa (MEA)

The market research study on “Personalized Medicine Market - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026” offers detailed insights on global Personalized Medicine market segments with market dynamics and their impact. The report also covers basic technology development policies.

This Report offers an assessment of the most recent developments in each sub-segment from 2015 until 2026 and offers a forecast of revenues and volume growth at worldwide, regional and national levels. ARC segmented the worldwide personalized medicine (PM) report on the product and region for the purpose of this research:

Key Questions Answered in the Report

The report addresses key questions concerning the market evolution and overarching trends shaping global market growth. Some of the key questions answered in the report include-

What is the overall structure of the market?

What was the historical value and what is the forecasted value of the market?

What are the key product level trends in the market?

What are the market level trends in the market?

Which of the market players are leading and what are their key differential strategies to retain their stronghold?

Which are the most lucrative regions in the market space?

Buy this Premium Research Report@ https://www.acumenresearchandconsulting.com/buy-now/0/1466

Research Methodology

The report on the Personalized Medicine Market is based on an extensive and meticulous bottom up approach, which was used to determine the market size.

In the primary phase of the research methodology focus on, key stakeholders, including CEOs, presidents, vice presidents, chief medical officers, and product/sales/marketing managers were interviewed for the purpose of garnering unique insights into the dynamics of the market.

Market Participants:

Key companies in this market are Illumina, Inc.; Danaher Corporation Asuragen, Inc.; Abbott Laboratories; GE Healthcare; Dako A/S; Exagen Diagnostics, Inc.; Exact Science Corporation;Decode Genetics, Inc.; QIAGEN; Celera Diagnostics LLC; Genelex Corporation; Precision Biologics, Inc.; and Biogen, Inc.

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Personalized Medicine
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Personalized Medicine Market By Product
1.2.2.1. Global Personalized Medicine Market Revenue and Growth Rate Comparison By Product (2015-2026)
1.2.2.2. Global Personalized Medicine Market Revenue Share By Product in 2017
1.2.2.3. Therapeutics
1.2.2.4. Diagnostics
1.2.2.5. Personalized Nutrition & Wellness
1.2.2.6. Personalized Medical Care
1.2.3. Personalized Medicine Market by Geography
1.2.3.1. Global Personalized Medicine Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.3.2. North America Personalized Medicine Market Revenue and Growth Rate (2015-2026)
1.2.3.3. Europe Personalized Medicine Market Revenue and Growth Rate (2015-2026)
1.2.3.4. Asia-Pacific Personalized Medicine Market Revenue and Growth Rate (2015-2026)
1.2.3.5. Latin America Personalized Medicine Market Revenue and Growth Rate (2015-2026)
1.2.3.6. Middle East and Africa (MEA) Personalized Medicine Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Personalized Medicine Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Personalized Medicine Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Personalized Medicine Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Personalized Medicine Major Manufacturers in 2017

CHAPTER 4. PERSONALIZED MEDICINE MARKET BY PRODUCT

4.1. Global Personalized Medicine Revenue By Product
4.2. Therapeutics
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Diagnostics
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Personalized Nutrition & Wellness
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Personalized Medical Care
4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. NORTH AMERICA PERSONALIZED MEDICINE MARKET BY COUNTRY

5.1. North America Personalized Medicine Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2. North America Personalized Medicine Market Revenue Share Comparison, 2015 & 2026 (%)
5.3. U.S.
5.3.1. U.S. Personalized Medicine Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
5.4. Canada
5.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
5.5. Mexico
5.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

CHAPTER 6. EUROPE PERSONALIZED MEDICINE MARKET BY COUNTRY

6.1. Europe Personalized Medicine Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2. Europe Personalized Medicine Market Revenue Share Comparison, 2015 & 2026 (%)
6.3. UK
6.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
6.4. Germany
6.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
6.5. France
6.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
6.6. Spain
6.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
6.7. Rest of Europe
6.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

CHAPTER 7. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET BY COUNTRY

7.1. Asia-Pacific Personalized Medicine Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. Asia-Pacific Personalized Medicine Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. China
7.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.4. Japan
7.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.5. India
7.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.6. Australia
7.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.7. South Korea
7.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.8. Rest of Asia-Pacific
7.8.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

CHAPTER 8. LATIN AMERICA PERSONALIZED MEDICINE MARKET BY COUNTRY

8.1. Latin America Personalized Medicine Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Latin America Personalized Medicine Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. Brazil
8.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.4. Argentina
8.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.5. Rest of Latin America
8.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

CHAPTER 9. MIDDLE EAST PERSONALIZED MEDICINE MARKET BY COUNTRY

9.1. Middle East Personalized Medicine Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Middle East Personalized Medicine Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. Saudi Arabia
9.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.4. UAE
9.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.5. Rest of Middle East
9.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

CHAPTER 10. AFRICA PERSONALIZED MEDICINE MARKET BY COUNTRY

10.1. Africa Personalized Medicine Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Africa Personalized Medicine Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. South Africa
10.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.4. Egypt
10.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.5. Rest of Africa
10.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

CHAPTER 11. COMPANY PROFILE

11.1. Illumina, Inc.
11.1.1. Company Snapshot
11.1.2. Overview
11.1.3. Financial Overview
11.1.4. Product Portfolio
11.1.5. Key Developments
11.1.6. Strategies
11.2. Danaher Corporation
11.2.1. Company Snapshot
11.2.2. Overview
11.2.3. Financial Overview
11.2.4. Product Portfolio
11.2.5. Key Developments
11.2.6. Strategies
11.3. Asuragen, Inc.
11.3.1. Company Snapshot
11.3.2. Overview
11.3.3. Financial Overview
11.3.4. Product Portfolio
11.3.5. Key Developments
11.3.6. Strategies
11.4. Abbott Laboratories
11.4.1. Company Snapshot
11.4.2. Overview
11.4.3. Financial Overview
11.4.4. Product Portfolio
11.4.5. Key Developments
11.4.6. Strategies
11.5. GE Healthcare
11.5.1. Company Snapshot
11.5.2. Overview
11.5.3. Financial Overview
11.5.4. Product Portfolio
11.5.5. Key Developments
11.5.6. Strategies
11.6. Dako A/S
11.6.1. Company Snapshot
11.6.2. Overview
11.6.3. Financial Overview
11.6.4. Product Portfolio
11.6.5. Key Developments
11.6.6. Strategies
11.7. Exagen Diagnostics, Inc.
11.7.1. Company Snapshot
11.7.2. Overview
11.7.3. Financial Overview
11.7.4. Product Portfolio
11.7.5. Key Developments
11.7.6. Strategies
11.8. Exact Science Corporation
11.8.1. Company Snapshot
11.8.2. Overview
11.8.3. Financial Overview
11.8.4. Product Portfolio
11.8.5. Key Developments
11.8.6. Strategies
11.9. Decode Genetics, Inc.
11.9.1. Company Snapshot
11.9.2. Overview
11.9.3. Financial Overview
11.9.4. Product Portfolio
11.9.5. Key Developments
11.9.6. Strategies
11.10. QIAGEN
11.10.1. Company Snapshot
11.10.2. Overview
11.10.3. Financial Overview
11.10.4. Product Portfolio
11.10.5. Key Developments
11.10.6. Strategies
11.11. Celera Diagnostics LLC
11.11.1. Company Snapshot
11.11.2. Overview
11.11.3. Financial Overview
11.11.4. Product Portfolio
11.11.5. Key Developments
11.11.6. Strategies
11.12. Genelex Corporation
11.12.1. Company Snapshot
11.12.2. Overview
11.12.3. Financial Overview
11.12.4. Product Portfolio
11.12.5. Key Developments
11.12.6. Strategies
11.13. Precision Biologics, Inc.
11.13.1. Company Snapshot
11.13.2. Overview
11.13.3. Financial Overview
11.13.4. Product Portfolio
11.13.5. Key Developments
11.13.6. Strategies
11.14. Biogen, Inc.
11.14.1. Company Snapshot
11.14.2. Overview
11.14.3. Financial Overview
11.14.4. Product Portfolio
11.14.5. Key Developments
11.14.6. Strategies
11.15. Others
11.15.1. Company Snapshot
11.15.2. Overview
11.15.3. Financial Overview
11.15.4. Product Portfolio
11.15.5. Key Developments
11.15.6. Strategies

CHAPTER 12. RESEARCH APPROACH

12.1. Research Methodology
12.1.1. Initial Data Search
12.1.2. Secondary Research
12.1.3. Primary Research
12.2. Assumptions and Scope

To Purchase this Premium Report@ https://www.acumenresearchandconsulting.com/buy-now/0/1466

The report is readily available and can be dispatched immediately after payment confirmation.

Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.